In our study, it was hypertension and hepatic steatosis that were significantly associated with the highest risk of MAC, followed by HOMA C-peptide and of TNF-α, which were also predictive of MAC presence; a 1% increase in either was associated with substantially higher odds of MAC presence (20.7% and 12.5%, respectively). This evidence concerns the gene TNF and Hepatic steatosis.